Eupraxia Pharmaceuticals (EPRX) Prepaid Assets (2022 - 2026)

Eupraxia Pharmaceuticals' (EPRX) quarterly Prepaid Assets came in at $2.6 million in Q1 2026, up 182.83% year-on-year from $913283.0 in Q1 2025, and down 33.1% on a QoQ basis from $3.9 million in Q4 2025.

Eupraxia Pharmaceuticals (EPRX) Prepaid Assets (2022 - 2026) Analysis & Trends

Eupraxia Pharmaceuticals (EPRX) has 5 years of Prepaid Assets data on file, last reported at $2.6 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 182.83% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 182.83% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 248.92% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $2.6 million, down from $3.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for EPRX reached as high as $3.9 million in Q4 2025 and fell as low as $140928.0 in Q1 2024.
  • Historically, Prepaid Assets has averaged $1.6 million across 5 years, with a median of $1.1 million in 2024.
  • Across the five-year window, Prepaid Assets climbed 14.75% in 2023 and jumped 548.05% in 2025, its largest moves.
  • Year by year, Prepaid Assets stood at $235903.0 in 2022, then advanced by 14.75% to $270710.0 in 2023, then soared by 308.74% to $1.1 million in 2024, then jumped by 248.92% to $3.9 million in 2025, then sank by 33.1% to $2.6 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $2.6 million in Q1 2026, $3.9 million in Q4 2025, and $2.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Eupraxia Pharmaceuticals 329.50 Mn 329.50 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.58 Mn
Dec 31, 2025 3.86 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 2.93 Mn
Mar 31, 2025 913,283.00
Dec 31, 2024 1.11 Mn
Mar 31, 2024 140,928.00
Dec 31, 2023 270,710.00
Dec 31, 2022 235,903.00